Drugs & Side Effects | COX-2 / Arthritis

Vioxx News

Suits that Merck Won, May be in Jeopardy

RSS News Feeds
Drugs & Pharmacuticals
Stroke
Vioxx
 All RSS Feeds

At a glance:

Lawyers who lost Vioxx cases to Merck (three such cases, so far) are encouraged by the news that the New England Journal of Medicine has issued a correction with regard to a Vioxx study it published last year. The correction removed references to the crucial 18 month time period that Merck claims is a safe period before heart side effects kick in. 
 
This time frame was a critical aspect of Merck's defense against liability for those who suffered heart attacks while taking Vioxx. 
 
The plaintiffs in question have petitioned for new trials.

Plaintiff Lawyers Like Vioxx Correction

MSN Money - 6/27/2006 6:32 PM

Lawyers who lost their Vioxx cases said Tuesday they see new ammunition in their fights to win new trials now that a prominent medical journal has contradicted a key defense used by Merck & Co.
 
On Monday, the New England Journal of Medicine issued a correction which reversed an article's claim that Vioxx elevated the risk of cardiovascular problems only after 18 months of use. However, the correction didn't state when the increased risk would begin
 
· Read The Full Vioxx Article From MSN Money -->

· Read All Vioxx (Rofecoxib) News Stories -->

Comments On Vioxx News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: